# SOLE SOURCE- Fetal Bovine Serum Canonical: https://abierto.us/opportunities/fdarfq25q2267048 - Solicitation number: FDARFQ25Q2267048 - Notice type: Combined synopsis and solicitation - Status: Awarded to Fisher Scientific Company L.L.C. - Department: Department of Health and Human Services - Agency: Food and Drug Administration - Contracting office: FDA Office of Acq Grant SVCS (75F401) - NAICS: 424590 Other Farm Product Raw Material Merchant Wholesalers - Product or service code: 9430 Miscellaneous Crude Animal Products, Inedible - Place of performance: Maryland - County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031 - First posted: September 15, 2025 - Last posted: September 15, 2025 - SAM.gov: https://sam.gov/workspace/contract/opp/5b7d95adb2e3466aa88caa4193482df4/view ## Description **Disclaimer:** This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This solicitation is being issued on behalf of NIH The Government intends to negotiate and solicit with only one source, Fisher Scientific Company, LLC, 300 Industry Drive, Pittsburgh, PA, 15275, under the authority of FAR (13.106(b)(1)(i). This is not a request for competitive proposals, however, any responsible offeror may submit a quote which will be given due consideration by the agency. (ii) This acquisition is issued as a Request for Quote (RFQ). (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06, 08/26/2025. (iv) For purposes of this acquisition, the associated NAICS code is 424590. The small business size standard is 175 employees. This action is being solicited as a Full and Open. (v) Line-Item Structure: The following is a list of line-item number(s) and items, quantities and units of measure, (including option(s), if applicable) and should be reflected in the Offeror’s quote/proposal: **Line Item 0001:** HI Fetal Bovine Serum, PREMIUM PLUS 500ML 500M, 200 EA. (vi) **Specifications/Requirement:** The Contractor shall provide HI FBS PREMIUM PLUS 500ML 500M, 200 units each. (vii) **Delivery:** Delivery is required by 4/5/2025. Delivery shall be made to: Building 50, Room 6310 50 South Drive Bethesda, MD 20892 The FOB point is destination. (viii) The provision at 52.212-1, Instructions to Offerors – Commercial DEVIATION 2018-O0018, applies to this acquisition. The following addenda have been attached to this provision: In addition to the requirements set for the in FAR 52.212-1, all offers responding to this solicitation must provide their business size in relation to the NAICS code contained in this solicitation and shall identify any socioeconomic categories to which they belong. (ix) Evaluation Criteria - The specific evaluation criteria to be used are as follows: N/A (x) Offerors shall include a completed copy of the provision at FAR 52.212-3 (with its Alternate I), Offeror Representations with its offer. (xi) The clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addenda have been attached to this clause NONE. (xii) The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition. The following additional FAR clauses cited in this clause are applicable: 52.203-17, Contractor Employee Whistleblower Rights (Nov 2023) 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards (Jun 2020) 52.204-27, Prohibition on a ByteDance Covered Application (Jun 2023) 52.209-6, Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (Nov 2021) 52.219-28, Post Award Small Business Program Rerepresentation (Feb 2024) 52.222-3, Convict Labor (Jun 2003) 52.222-21, Prohibition of Segregated Facilities (Apr 2015) 52.222-26, Equal Opportunity (Sep 2016) 52.222-36, Equal Opportunity for Workers with Disabilities (Jun 2020) 52.225-13, Restrictions on Certain Foreign Purchases (Feb 2021) 52.226-8, Encouraging Contractor Policies to Ban Text Messaging While Driving (May 2024) 52.232-33, Payment by Electronic Funds Transfer-System for Award Management (Oct2018) (xiii) The following additional contract requirement(s) or terms and conditions apply: 52.204-7 SYSTEM FOR AWARD MANAGEMENT (OCT 2018) 52.204-13 SYSTEM FOR AWARD MANAGEMENT MAINTENANCE (OCT 2018) 52.204-16 COMMERCIAL AND GOVERNMENT ENTITY CODE REPORTING (JUL 2016) 52.204-18 COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE (JUL 2016) 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (AUG 2019) 52.232-40 PROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS (DEC 2013) 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 15) 352.239-73 Electronic and Information Technology Accessibility Notice (Dec 15) (xiv) This acquisition is rated under the Defense Priorities and Allocations System (DPAS) as N/A. (xv) Date, Time, and Place offers are due: 11:59pm EDT 9/18/2025 (xvi) Name and Telephone Number of the Individual to Contact for Information Regarding the Solicitation: **James O’Keefe III, Tel:** 301-796-7371 james.okeefeiii@fda.hhs.gov ## Award on USAspending - Recipient: Fisher Scientific Company L.L.C. (UEI HE7NJQGP4ED6) - Contract: 75N93025P01122, purchase order - Obligated: $100,000.00 - Competition: Not Competed Under SAP, 1 offers received - Link: solicitation number FDARFQ25Q2267048 equals the FPDS solicitation identifier; awarding office not confirmed (medium confidence) - Record: https://www.usaspending.gov/award/CONT_AWD_75N93025P01122_7529_-NONE-_-NONE-/ ## Publications - September 15, 2025: Combined synopsis and solicitation, due September 18, 2025 at 11:59 PM EDT. Notice 5b7d95adb2e3466aa88caa4193482df4. https://sam.gov/workspace/contract/opp/5b7d95adb2e3466aa88caa4193482df4/view ## Points of contact - James O’Keefe, James.OKeefeIII@fda.hhs.gov, 3017967371 --- Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdarfq25q2267048.